Stock Based Compensation - Mirati Therapeutics Inc (NASDAQ:MRTX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 58.7 USD

Updated:

Mirati Therapeutics Inc
Stock-Based Compensation

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Mirati Therapeutics Inc
Stock-Based Compensation Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Stock-Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Mirati Therapeutics Inc NASDAQ:MRTX	Stock-Based Compensation $192.5m	CAGR 3-Years 34%	CAGR 5-Years 72%	CAGR 10-Years 54%
	Abbvie Inc NYSE:ABBV	Stock-Based Compensation $782m	CAGR 3-Years -1%	CAGR 5-Years 13%	CAGR 10-Years 13%
	Gilead Sciences Inc NASDAQ:GILD	Stock-Based Compensation $788m	CAGR 3-Years 7%	CAGR 5-Years 1%	CAGR 10-Years 11%
	Amgen Inc NASDAQ:AMGN	Stock-Based Compensation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Stock-Based Compensation $650.7m	CAGR 3-Years 15%	CAGR 5-Years 14%	CAGR 10-Years 16%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Stock-Based Compensation N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Stock-Based Compensation amounts to 192.5m USD.

Over the last year, the Stock-Based Compensation growth was 21%. The average annual Stock-Based Compensation growth rates for Mirati Therapeutics Inc have been 34% over the past three years , 72% over the past five years , and 54% over the past ten years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.